Actively Recruiting

Phase Not Applicable
Age: 13Years - 21Years
MALE
Healthy Volunteers
ID06525064

Health-E You/Salud iTu Pre-visit Mobile App for Male Adolescents to Promote Sexual and Reproductive Healthcare

Led by Johns Hopkins University · Updated on 2026-06-05

2752

Participants Needed

8

Research Sites

17 weeks

Total Duration

On this page

Sponsors

J

Johns Hopkins University

Lead Sponsor

E

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the Health-E You/Salud iTu, a web-based mobile app designed to help adolescent males and their clinicians discuss sexual and reproductive health (SRH) topics. This study focuses on male youth ages 13 to 21 and aims to test the app's effectiveness in clinical settings using a stepped wedge cluster randomized controlled trial. The goal is to improve condom use behaviors, knowledge about pregnancy and STI prevention, self-efficacy in male method use, and communication with clinicians about SRH. The app is provided to participants before their clinic visit and takes about 10 to 15 minutes to complete. It offers tailored health information based on initial questions answered by the adolescent and shares relevant patient information with clinicians to support the visit. Clinics alternate between usual care and the intervention, with participants either receiving the app or standard care, ensuring that each participant only uses the app once. The study involves no direct interaction with interventionists. Participants will complete a baseline assessment, use the app if in the intervention group, and then complete follow-up assessments immediately after the visit and two months later. Researchers will measure outcomes including condom use self-efficacy, patient-physician interaction efficacy, frequency of condom use, and receipt of sexual and reproductive care. The study spans from baseline through a 2-month post-visit follow-up, marking the end of participation.

CONDITIONS

Brief Title

Health-E You Efficacy Trial for Male Adolescents

Who Can Participate

Age: 13Years - 21Years
MALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Assigned male sex at birth
  • Age 13 to 21 years old
  • English and/or Spanish as preferred language to read, listen, and converse
  • Self-reported engagement in vaginal and/or anal sex in the past 12 months
  • Access to phone or internet for follow-up study activities
Not Eligible

You will not qualify if you...

  • Age 12 or younger or older than 21
  • Primary language other than English or Spanish
  • Not able to provide informed consent
  • Unable to communicate due to cognitive, mental, language, or other difficulties
  • Not sexually active, engaged in oral sex only, or more than 12 months since last vaginal and/or anal sex
  • Previous participation in a Health-E You study activity or the app

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit

Treatment

Duration - Single pre-visit completion

Participants complete the Health-E You app before their clinic visit, which takes approximately 10-15 minutes and provides tailored sexual and reproductive health information to support discussions with their clinician.

1 visit (pre-visit app completion)

Follow-up

Duration - 2 months after the clinic visit

Participants complete an immediate follow-up assessment after the visit and a 2-month post-visit follow-up assessment to evaluate changes in sexual and reproductive health behaviors and knowledge.

2 follow-up assessments (immediate and 2-month post-visit)

Trial Site Locations

Total: 8 locations

1

UCSF Benioff Children's Hospital - Oakland

Oakland, California, United States, 94609

Actively Recruiting

2

Children's National Hospital

Washington D.C., District of Columbia, United States, 20012

Actively Recruiting

3

Johns Hopkins University

Baltimore, Maryland, United States, 21287

Actively Recruiting

4

Mount Sinai Health System

New York, New York, United States, 10128

Actively Recruiting

5

Upstate University Hospital

Syracuse, New York, United States, 13210

Actively Recruiting

6

Cincinnati Children's Hospital

Cincinnati, Ohio, United States, 45229

Actively Recruiting

7

Penn State Health

Hershey, Pennsylvania, United States, 17033

Actively Recruiting

8

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

A

Arik V Marcell, MD, MPH

S

Sofia Osio, MSPH

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Apple Women's Health Study

Menstrual Cycle

Actively Recruiting

1 location

Assessment of the Psychosocial Sexual Health Competencies of...

Sexual Health

Actively Recruiting

1 location

Comparing Mobile Health Strategies to Improve Pre-exposure P...

HIV Infections

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Improving contraceptive use among Latina adolescents: A cluster-randomized controlled trial evaluating an mHealth application, Health-E You/Salud iTu.

Kathleen P Tebb, Felicia Rodriguez, Lance M Pollack...

https://pubmed.ncbi.nlm.nih.gov/33744300

A Previsit Mobile Health App (Health-E You/Salud iTu) for Male Adolescents to Promote Sexual and Reproductive Health Care Receipt: Protocol for a Randomized Controlled Trial.

Arik V Marcell, Annie D Smith, Sofia Osio Smith...

https://pubmed.ncbi.nlm.nih.gov/41092393